2025-23717Rule

DEA Schedules Two Potent Synthetic Opioids in Strictest Ban Category

Published Date: 12/23/2025

Rule

Summary

Starting January 22, 2026, two powerful drugs called N-desethyl isotonitazene and N-piperidinyl etonitazene will be officially banned and placed in the toughest drug category, Schedule I. This means anyone making, selling, or using these drugs will face serious legal trouble. This move helps the U.S. follow international drug rules and keeps communities safer without adding new costs.

Analyzed Economic Effects

3 provisions identified: 0 benefits, 3 costs, 0 mixed.

Manufacturers and Distributors Face Schedule I Controls

Starting January 22, 2026, manufacturers, distributors, importers, and exporters of N-desethyl isotonitazene and N-piperidinyl etonitazene must be registered with the DEA and follow Schedule I rules. That includes following 21 U.S.C. registration and quota rules, keeping inventories (initial inventory and new inventories every two years), meeting security and labeling rules, submitting reports to the Automation of Reports and Consolidated Order System, and obeying order-form, import/export, and disposal rules; violations may bring administrative, civil, or criminal penalties.

Researchers and Instructional Users Must Register

From January 22, 2026, anyone who engages in research or instructional activities with these two substances must register with DEA and follow Schedule I requirements such as security screening, labeling and packaging rules, disposal under 21 CFR part 1317, and recordkeeping and reporting obligations. All research or instructional use is subject to the same inventory, security, and reporting rules that apply to Schedule I controlled substances.

Possession or Retail Sales Will Be Unlawful

Effective January 22, 2026, possession of any quantity of N-desethyl isotonitazene or N-piperidinyl etonitazene without DEA authorization is unlawful and may lead to prosecution, and retail sales of Schedule I substances to the general public are not allowed under the Controlled Substances Act. Unauthorized activities involving these substances may result in administrative, civil, and criminal sanctions.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Rule Effective
12/23/2025
1/22/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in